HEALTHCARE VENTURES VII LP 4
4 · PHARMATHENE, INC · Filed Nov 5, 2010
Insider Transaction Report
Form 4
HEALTHCARE VENTURES VII LP
10% Owner
Transactions
- Conversion
Common Stock
2010-11-03$2.54/sh+935,814$2,378,558→ 4,253,057 total(indirect: By Partnership) - Conversion
10% Convertible Note
2010-11-03−935,814→ 0 total(indirect: By Partnership)Exercise: $2.54Exp: 2011-07-28→ Common Stock (935,814 underlying)
Footnotes (4)
- [F1]These securities are owned by HealthCare Ventures VII, L.P. ("HCVVII"). These securities are indirectly owned by HealthCare Partners VII, L.P. ("HCPVII"), the General Partner of HCVVII and each of James Cavanaugh, Harold Werner, John Littlechild, Christopher Mirabelli and Augustine Lawlor, the general partners of HCPVII. Drs. Cavanaugh and Mirabelli and Messrs. Werner, Littlechild and Lawlor disclaim beneficial ownership of those securities in which they do not have a pecuniary interest and this report shall not be deemd an admission that they are the beneficial owners of these securities for purposes of Section 16. In addition, James Cavanaugh is a Director of the Issuer.
- [F2]The 10% Convertible Note (the "Note") together with accrued interest was convertible into the Issuer's Common Stock at a price of $2.541667 per share. The total number of shares acquired includes 829,173 shares of Common Stock underlying the Note together with 106,641 shares of Common Stock representing accrued interest under the Note.
- [F3]Immediately.
- [F4]This Note together with a Warrant was received pursuant to a Note and Warrant Purchase Agreement dated as of July 24, 2009, as amended on July 26, 2009 and July 28, 2009, by and among the Issuer and certain noteholders, all as more specifically reported on Form 4 filed with the Securities & Exchange Commission on July 30, 2009.